-
Posted by
Two Blokes May 24, 2025 -
Filed in
Stock
-
7 views
WELL Health is an undervalued, high-growth, cash-generating small-cap with a unique Canadian market opportunity and significant upside from planned US divestitures. Management's focus on exiting US operations and reinvesting in Canadian clinics should unlock value, given higher ROI less risk in Canada. Strong Q1 results, falling stock-based compensation, robust 2025 guidance, and a renewed buyback program reinforce my conviction in a Strong Buy rating.
